Osteoporosis in men is dramatically underdiagnosed — and low testosterone is one of the leading causes. Men account for 30% of all hip fractures, yet fewer than 10% receive bone density screening before their first fracture. TRT has consistent, well-documented effects on bone mineral density that represent one of the most compelling reasons to treat hypogonadism in men over 45.
How Testosterone Affects Bone
Testosterone influences bone density through two pathways:
- Direct androgen receptor pathway: Testosterone binds androgen receptors on osteoblasts (bone-forming cells), stimulating bone formation and reducing resorption
- Aromatization to estradiol: ~20% of testosterone converts to estradiol in men. Estradiol is critical for bone maintenance — this is why men with low estradiol (from low T or aggressive AI use) lose bone rapidly
Clinical Evidence: TRT and Bone Density
| Study | Duration | Lumbar Spine BMD | Hip BMD |
|---|---|---|---|
| TRAVERSE (2023) | 22 months | +3.5% | +1.8% |
| TTrials Bone (2015) | 12 months | +7.5% | Not reported |
| Stoch et al. 2009 | 36 months | +5.1% | +2.5% |
| Snyder et al. 1999 | 36 months | +5.9% | +1.5% |
The Testosterone Trials specifically measured bone density. Men on TRT for 12 months gained 7.5% lumbar spine BMD vs placebo. Most osteoporosis medications target 3–5% annual gains. TRT outperforms them in hypogonadal men — while also treating the root cause.
Fracture Risk and Low Testosterone
- Men with total testosterone below 200 ng/dL have 2–3x higher hip fracture incidence vs men above 400 ng/dL
- Hypogonadal men lose bone at 2–3% per year vs 0.5–1% in eugonadal men
- After hip fracture, men have 37% mortality within 1 year — far worse outcomes than women with the same fracture
- Male osteoporosis is not a “women’s disease” edge case — it kills men at high rates
DEXA Scan: T-Scores and What They Mean
| T-Score | Classification | Fracture Risk vs Normal |
|---|---|---|
| Above -1.0 | Normal | Baseline |
| -1.0 to -2.5 | Osteopenia | Elevated 1.5–2x |
| Below -2.5 | Osteoporosis | Elevated 2–4x |
Men on TRT with baseline osteopenia should repeat DEXA at 24 months. Men with normal baseline BMD can reassess at 5 years. TRT typically produces measurable improvement at 24-month DEXA in men who were deficient at baseline.
The Estradiol Factor: Why AI Use Destroys Bone
This is underappreciated and critically important: men who use aromatase inhibitors (anastrozole, letrozole) aggressively to suppress estradiol on TRT are directly accelerating bone loss.
- Optimal estradiol for bone density in men: 20–40 pg/mL
- Below 20 pg/mL: Rapid bone loss begins
- Many “bro science” AI protocols target estradiol below 10 pg/mL — this is clinically dangerous for bone
Viking’s estradiol protocol targets 20–50 pg/mL with symptom guidance. We do not reflexively prescribe anastrozole for elevated estradiol numbers if the patient is asymptomatic — because doing so trades comfort for accelerated bone destruction.
TRT vs Bisphosphonates for Male Osteoporosis
For hypogonadal men with osteoporosis or osteopenia, TRT is typically first-line bone therapy — not bisphosphonates (alendronate, risedronate). Why:
- TRT addresses the root hormonal cause; bisphosphonates only treat bone turnover
- TRT produces anabolic (bone-building) effects; bisphosphonates are primarily anti-resorptive
- TRT simultaneously improves muscle mass, reducing fall risk — the other half of fracture prevention
- Long-term bisphosphonate use carries its own risks: osteonecrosis of the jaw, atypical femur fractures at 5+ years
Does TRT increase bone density?
Yes. Multiple RCTs show TRT increases lumbar spine BMD by 3.5–7.5% over 12–22 months — comparable to or exceeding most osteoporosis medications in hypogonadal men.
Can low testosterone cause osteoporosis in men?
Yes. Hypogonadal men lose bone at 2–3%/year. Men below 200 ng/dL have 2–3x higher hip fracture risk. Men have 37% mortality at 1 year post-hip-fracture — this is not trivial.
How does estradiol affect bone density in men on TRT?
Estradiol is critical for male bone density. Aggressive AI use to crash estradiol below 20 pg/mL accelerates bone loss. Viking targets 20–50 pg/mL — treating symptoms without destroying bone.
Should men on TRT get a DEXA scan?
Men over 50 with hypogonadism or osteopenia risk factors should get a baseline DEXA. Men on TRT with baseline osteopenia should repeat at 24 months to confirm TRT is rebuilding bone.
Recent Comments